How the Street's calls on biotech played out
Sell-side price targets on biotech names over the last two years, checked over each firm's own horizon: 131 of 363 resolved targets (36%) were reached while they stood, 219 were replaced by the same firm first, and 13 fell short at their deadline.
5 names · 16 firms with 8+ resolved targets here · checked through 2026-10-29. Rebuilt every morning.
Firm by firm on biotech
| # | Firm | Targets reached | Replaced early | Short | Resolved | Ratings vs sector | Names |
|---|---|---|---|---|---|---|---|
| 1 | RBC Capital | 10 (26%) | 29 | 0 | 39 | 1 of 1 | AMGN GILD MRNA REGN VRTX |
| 2 | Morgan Stanley | 7 (18%) | 31 | 0 | 38 | 1 of 1 | AMGN GILD MRNA REGN VRTX |
| UBS | 9 (36%) | 16 | 0 | 25 | 0 of 2 | AMGN GILD MRNA REGN VRTX | |
| Truist Securities | 8 (35%) | 15 | 0 | 23 | 0 of 3 | AMGN GILD REGN VRTX | |
| Citigroup | 8 (36%) | 14 | 0 | 22 | 2 of 3 | AMGN GILD MRNA REGN VRTX | |
| Piper Sandler | 5 (25%) | 12 | 3 | 20 | 2 of 5 | AMGN GILD MRNA REGN VRTX | |
| Wells Fargo | 9 (50%) | 9 | 0 | 18 | 1 of 2 | AMGN GILD REGN VRTX | |
| Cantor Fitzgerald | 14 (82%) | 3 | 0 | 17 | 0 of 2 | AMGN GILD REGN VRTX | |
| BMO Capital | 5 (29%) | 11 | 1 | 17 | 3 of 4 | AMGN GILD REGN VRTX | |
| JPMorgan | 6 (35%) | 11 | 0 | 17 | 3 of 4 | GILD MRNA REGN VRTX | |
| Barclays | 4 (27%) | 10 | 1 | 15 | 0 of 1 | AMGN GILD MRNA REGN VRTX | |
| Bank of America | 4 (29%) | 10 | 0 | 14 | 1 of 4 | AMGN GILD MRNA REGN VRTX | |
| Canaccord Genuity | 6 (50%) | 6 | 0 | 12 | 1 of 1 | AMGN REGN VRTX | |
| Oppenheimer | 2 (18%) | 8 | 1 | 11 | 1 of 2 | AMGN GILD REGN VRTX | |
| Guggenheim | 2 (22%) | 6 | 1 | 9 | 1 of 2 | AMGN REGN VRTX | |
| Goldman Sachs | 3 (38%) | 4 | 1 | 8 | 1 of 1 | AMGN GILD MRNA REGN |
Numbered firms have 30+ resolved targets in this sector and are ordered by the share reached; the rest are listed by volume, unranked. A record inside one sector is a slice of a slice: none of these counts is a measure of skill, and none carries a letter. How targets and ratings are checked →
The names
Other sectors
How calls are checked
Every call is checked on the firm's own terms. A price target is followed until its own deadline (12 months unless the firm publishes a different horizon) and ends as reached (the stock closed at or beyond it while it stood), replaced (the same firm set a new target first) or short at deadline. A rating is compared with the stock's sector SPDR ETF on total return over the rating's life, because most big-firm ratings are relative: Overweight means "beat its peers", not "go up". Hold-type ratings are tracked, not graded. A firm is numbered only with 30+ resolved targets, and a letter prints only for a firm's whole record where an exact test separates it from a coin flip. None of this is a verdict on anyone's skill, and one day is never a grade. The full method →
Get the calls before they're checked
Our take, the S&P 500 Pulse, the Street's calls and today's docket — one email, weekdays, 9 AM ET, 30 minutes before the open.